Celon Pharma SA (CLN) — Capital Reinvestment Ratio
Celon Pharma SA (CLN) has a Capital Reinvestment Ratio of 0.72x as of December 2025, meaning it reinvests 1% of its operating cash flow (zł36.63 Million) in capital expenditures (zł26.48 Million). Check tangible net worth ratio of Celon Pharma SA to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Celon Pharma SA Capital Reinvestment Ratio (2012–2025)
This chart tracks Celon Pharma SA's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Celon Pharma SA cash conversion from operations.
Annual Capital Reinvestment Ratio for Celon Pharma SA (2012–2025)
Year-by-year Capital Reinvestment Ratio for Celon Pharma SA from 2012 to 2025. See CLN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.28x | zł23.86 Million | zł54.44 Million | ▲ +142.4% |
| 2021 | 0.94x | zł43.95 Million | zł41.35 Million | ▼ -32.7% |
| 2020 | 1.40x | zł70.90 Million | zł99.16 Million | ▼ -41.5% |
| 2018 | 2.39x | zł28.24 Million | zł67.46 Million | ▲ +92.9% |
| 2017 | 1.24x | zł25.30 Million | zł31.34 Million | ▲ +20.1% |
| 2016 | 1.03x | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł12.87 Million | zł4.34 Million | — |